Clinical Trial: OE MRI to Predict Treatment Response After TACE in HCC Patients

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617038) titled 'OE MRI to Predict Treatment Response After TACE in HCC Patients' on April 16.

Brief Summary: To predict response of HCC to TACE using dynamic oxygen-enhanced (dOE)-MRI for assessment of the level of tumor hypoxia before and after treatment.

Study Start Date: Nov. 27, 2024

Study Type: INTERVENTIONAL

Condition: HCC - Hepatocellular Carcinoma TACE SIRT

Intervention: DIAGNOSTIC_TEST: MRI contrast-enhancing agents

MRI before and after treatment

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Universite de Montreal

Information provided by (Responsible Party): Audrey Fohlen, Centre hospitalier de l'Universite de Montreal (CHU...